Related Experiment Video
Updated: Jul 30, 2025
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological
Rebekah Tillotson1,2, Keqin Yan3, Julie Ruston1
1Genetics and Genome Biology Program, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, ON M5G 0A4, Canada.
Abstract:
ATRX is a chromatin remodelling ATPase that is involved in transcriptional regulation, DNA damage repair and heterochromatin maintenance. It has been widely studied for its role in ALT-positive cancers, but its role in neurological function remains elusive. Hypomorphic mutations in the X-linked ATRX gene cause a rare form of intellectual disability combined with alpha-thalassemia called ATR-X syndrome in hemizygous males. Clinical features also include facial dysmorphism, microcephaly, short stature, musculoskeletal defects and genital abnormalities. As complete deletion of ATRX in mice results in early embryonic lethality, the field has largely relied on conditional knockout models to assess the role of ATRX in multiple tissues. Given that null alleles are not found in patients, a more patient-relevant model was needed. Here, we have produced and characterized the first patient mutation knock-in model of ATR-X syndrome, carrying the most common causative mutation, R246C. This is one of a cluster of missense mutations located in the chromatin-binding domain and disrupts its function. The knock-in mice recapitulate several aspects of the patient disorder, including craniofacial defects, microcephaly, reduced body size and impaired neurological function. They provide a powerful model for understanding the molecular mechanisms underlying ATR-X syndrome and testing potential therapeutic strategies.
Insights
Researchers developed a new mouse model for ATR-X syndrome, a rare intellectual disability. This model, carrying a common ATRX gene mutation, helps study the disorder's neurological impacts and test therapies.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- The ATRX gene encodes a chromatin remodelling ATPase crucial for DNA repair and gene regulation.
- While ATRX is studied in cancer, its role in neurological function is not well understood.
- ATRX mutations cause ATR-X syndrome, a rare intellectual disability with distinct clinical features.
Purpose of the Study:
- To create and characterize a patient-relevant mouse model for ATR-X syndrome.
- To investigate the neurological and developmental consequences of the common R246C ATRX mutation.
- To establish a platform for exploring therapeutic strategies for ATR-X syndrome.
Main Methods:
- Generation of a knock-in mouse model carrying the specific R246C mutation in the ATRX gene.
- Phenotypic characterization of the knock-in mice, focusing on neurological and developmental aspects.
- Comparison of knock-in mouse phenotypes with clinical features of human ATR-X syndrome.
Main Results:
- The R246C ATRX knock-in mice exhibit craniofacial defects, microcephaly, and reduced body size.
- Impaired neurological function was observed in the knock-in mouse model.
- The model successfully recapitulates key aspects of human ATR-X syndrome.
Conclusions:
- The developed ATRX knock-in mouse model is a valuable tool for studying ATR-X syndrome.
- This model facilitates research into the molecular mechanisms underlying ATR-X syndrome's neurological deficits.
- It provides a preclinical platform for testing novel therapeutic interventions.
